GlassScriptPhysician profile
Michael S Burke
NPI 1306027362
$3,354.63
in general payments reported to CMS, 2019-2025
23 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,078 · 2020: $762 · 2021: $32.57 · 2022: $32.99 · 2023: $157 · 2024: $101 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $987.62 | 2019-2025 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $594.18 | 2019-2023 | Watchman Flx |
| Lilly USA, LLC | $433.84 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $275.63 | 2019 | |
| Pfizer INC. | $184.82 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $156.41 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $137.59 | 2019-2020 | |
| Allergan, INC. | $125.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $122.76 | 2019-2025 | Airsupra |
| Exact Sciences Corporation | $54.18 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Insmed, INC. | $50.38 | 2024-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $30.35 | 2019 | |
| Gilead Sciences, INC. | $24.39 | 2025 | |
| Amgen INC. | $23.82 | 2019-2020 | |
| Smith+Nephew, INC. | $23.54 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalpropion Pharmaceuticals LLC | $19.37 | 2019 | |
| Antares Pharma, INC. | $18.86 | 2019 | |
| Stryker Corporation | $18.39 | 2025 | Artix Mt |
| Viiv Healthcare Company | $15.46 | 2024 | Apretude |
| Abbvie INC. | $15.39 | 2022 | |
| Amarin Pharma, INC. | $15.19 | 2019 | |
| Currax Pharmaceuticals LLC | $14.98 | 2019 | |
| Penumbra, INC. | $12.48 | 2024 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.